Abstract
Rationale
Methylphenidate, a dopaminergic and noradrenergic reuptake inhibitor, has been shown in young, healthy adult volunteers to produce pronounced effects on working memory and sustained attention. We were interested in assessing whether similar improvements could be conferred upon elderly volunteers in order to gain a more complete understanding of the effects of age on monoaminergic manipulations of working memory and attention, as well as to explore the potential for pharmacological intervention in attention and executive dysfunction disorders in this age group.
Objectives
The main aim of the study was to characterise the dose-related effects of methylphenidate on a range of neuropsychological functions in elderly healthy volunteers.
Methods
Sixty healthy elderly adult male volunteers received either a single oral dose of placebo, 20 mg or 40 mg methylphenidate prior to performing a variety of tasks designed to assess memory, attention and executive function. A randomised double-blind, between-subjects design was used.
Results
Methylphenidate had significant cardiovascular and subjective effects. However, unlike in younger volunteers, no significant effects of drug on working memory (spatial span and spatial working memory), response inhibition (stop-signal) or sustained attention (rapid visual information processing) were seen. Subtle effects on latency similar to those in younger volunteers were identified: both doses of methylphenidate resulted in a slowing in response time during set-shifting and decision-making.
Conclusions
The results of this study demonstrate that, in elderly subjects, the cognitive effects of methylphenidate are grossly attenuated and distinct from the profile previously described in younger volunteers. It is suggested that methylphenidate may not be appropriate as a pharmacological intervention in elderly patient groups, such as those reporting age-related cognitive decline.
Similar content being viewed by others
References
Arnsten AFT, Goldman-Rakic PS (1985) α2-Adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230:1273–1276
Arnsten AFT, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in cognitive performance of young adult and aged monkeys. Psychopharmacology 116:143–151
Arnsten AFT, Cai JX, Steere JC, Goldman-Rakic PS (1995) Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J Neurosci 15:3429–3439
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218
Cai JX, Arnsten AFT (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183–189
Camicioli R, Lea E, Nutt JG, Sexton G, Oken BS (2001) Methylphenidate increases the motor effects of l-dopa in Parkinson's disease: a pilot study. Clin Neuropharmacol 24:208–213
Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75:711–721
Deakin JB, Robbins TW, Sahakian BJ (2001) Ageing and conservatism in decision making. J Psychopharmacol 15: A38
Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131:196–206
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Galynker I, Ieronimo C, Miner C, Rosenblum J, Vilkas N, Rosenthal R (1997) Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiatr Clin Neurosci 9: 231–239
Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding YS (1996) Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 58:231–239
Goldman-Rakic PS, Brown RM (1981) Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6:177–187
Halliday R, Naylor H, Brandeis D, Callaway E, Yano L, Herzig K (1994) The effect of d-amphetamine, clonidine and yohimbine on human information processing. Psychophysiology 31:331–337
Harmer CJ, McTavish SF, Clark L, Goodwin GM, Cowen PJ (2001) Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology 154:105–111
Howell DC (1997) Statistical methods for psychology, 4th edn. Wadsworth, London
Kittur S, Hauser P (1999) Improvement of sleep and behaviour by methylphenidate in Alzheimer's disease. Am J Psychiatry 156:1116–1117
Koelega HS (1993) Stimulant drugs and vigilance performance: a review. Psychopharmacology 111:1–6
Lavretsky H, Kumar A (2001) Methylphenidate augmentation of citalopram in elderly depressed patients. Am J Geriatr Psychiatry 9:298–303
Logan GD (1994) On the ability to inhibit thought and action. In: Dagenbach D, Carr TH (eds) Inhibitory processes in attention, memory and language. Academic Press, San Diego, pp 189–239
Logan GD, Schachar RJ, Tannock R (1997) Impulsivity and inhibitory control. Psychol Sci 8: 60–64
Logan GD, Schachar RJ, Tannock R (2000) Executive control problems in childhood psychopathology: stop signal studies of attention deficit hyperactivity disorder. In: Monsell S, Driver J (eds) Control of cognitive processes: attention and performance XVIII. MIT Press, Cambridge, Mass., 653–677
Luciana M, Collins PF (1997) Dopaminergic modulation of working memory for spatial but not object cues in normal humans. J Cognit Neurosci 9:330–347
Luine V, Bowling D, Hearns M (1990) Spatial memory deficits in aged rats: contributions of monoaminergic systems. Brain Res 24:271–278
McKetin R, Ward PB, Catts SV, Mattick RP, Bell JR (1999) Changes in auditory selective attention and event-related potentials following oral administration of d-amphetamine in humans. Neuropsychopharmacology 21:380–390
McTavish SF, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ (2001) Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179:356–360
Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW (1999) Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology 146:162–174
Mehta MA, Swainson R, Ogilvie AD, Sahakian BJ, Robbins TW (2001) Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers. Psychopharmacology 159:10–20
Nelson H (1982) National adult reading test manual. Windsor NFER-Nelson, UK
Osman A, Kornblum S, Meyer DE (1990) Does motor programming necessitate response execution? J Exp Psychol [Hum Percep Perform] 16:183–198
Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28:1021–1034
Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW (1993) Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116:1159–1175
Owen AM, Sahakian BJ, Semple JM, Polkey CE, Robbins TW (1995) Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 13:1–24
Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33:575–588
Prendergast MA, Jackson WJ, Terry AV, Kille NJ, Arneric SP, Decker MW, Buccafusco JJ (1998) Age related differences in distractability and response to methylphenidate in monkeys. Cereb Cortex 8:164–172
Rabbitt P, Lowe C (2000) Patterns of cognitive ageing. Psychol Res 63:308–316
Rahman S, Sahakian BJ, Cardinal RN, Rogers RD, Robbins TW (2001) Decision making and neuropsychiatry. Trends Cognit Sci 5:271–277
Rapp PR, Amaral DG (1989) Evidence for task-dependent memory dysfunction in the aged monkey. J Neurosci 9:3568–3576
Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5:266–281
Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JFW, Sahakian BJ, Robbins TW (1999) Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implication for the monoaminergic basis of impulsive behaviour. Psychopharmacology 146:482–491
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 38:32–41
Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, Andrew C, Bullmore ET (2000) Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci Biobehav Rev 24:13–19
Sahakian BJ, Owen AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 5:399–402
Sahakian BJ, Morris R, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visuospatial memory and learning in Alzheimer type dementia and Parkinson's disease. Brain 111:695–718
Schenk S, Snow S, Horger BA (1991) Pre-exposure to amphetamine but not nicotine sensitizes rats to the motor activating effect of cocaine. Psychopharmacology 103:62–66
Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127–152
Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T, Tateno Y (1991) Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology 103:41–45
Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989) Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol. 17:473–491
Volkow ND, Wang G-J, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N (1997) Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154:50–55
Volkow ND, Wang G-J, Fowler JS, Gatley SJ, Logan J, Ding Y-S, Hitzemann R, Pappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325–1331
Volkow ND, Wang G-J, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Yuo Shin, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine. J Neurosci 21 (RC121):1–5
Wechsler D (1981) Wechsler Adult Intelligence Scale, revised. Psychological Corporation, New York
Wenk GL, Pierce DJ, Struble RG, Price DL, Cork LC (1989) Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging 10:11–19
West RL (1996) An application of prefrontal cortex function theory to cognitive aging. Psychol Bull 120:272–292
Zahrt J, Taylor JR, Matthew RG, Arnsten AFT (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528–8535
Acknowledgements
We thank the volunteers for participating in this study, which was funded by a Wellcome Trust Programme grant awarded to Professors T.W. Robbins, B.J. Everitt and B.J. Sahakian and Dr. A.C. Roberts and completed within the MRC Centre for Behavioural and Clinical Neuroscience. D.C.T. was funded by a MRC Research Studentship. The stop-signal task was developed under a Stroke Association grant to Professors Stephen Monsell and Ian Robertson.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Turner, D.C., Robbins, T.W., Clark, L. et al. Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology 168, 455–464 (2003). https://doi.org/10.1007/s00213-003-1457-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1457-3